跳至主要内容
临床试验/NCT02856282
NCT02856282已完成不适用

Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2016年2月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
1
主要终点
Number of Participants With Improved Symptoms Who Reduced the Doses to 1 Spray Per Nostril Per Day

研究概览

简要总结

The purpose is to obtain real-world information on how consumers are complying with the product labelling This study will coincide with the launch of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray in the United Kingdom (UK).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
4 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants will be required to review, and electronically sign a Participation Agreement prior to completing the online survey.
  • Participants of any age may participate.
  • Participants who have purchased and used Pirinase Hayfever Relief for Adults 0.05% Nasal Spray for at least 7 days and are willing to participate in the online survey.
  • Participants of either gender may participate

排除标准

  • Anyone who is directly involved with medicines such as doctors, nurses, and pharmacists.
  • Participants who decline participation in the online survey

研究组 & 干预措施

Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

Two sprays into each nostril once a day, preferably in the morning. Once symptoms are under control ,a maintenance dose of one spray may be used accordingly

干预措施: Pirinase Hayfever Relief for Adults 0.05% Nasal Spray (Drug)

结局指标

主要结局

Number of Participants With Improved Symptoms Who Reduced the Doses to 1 Spray Per Nostril Per Day

时间窗: 2 allergy seasons (up to a maximum of 2 years)

Participants who answered the question, 'Did you reduce the dose to 1 dose per nostril after your symptoms improved?', were evaluated to provide the data for this outcome measure.

Number of Participants Who Used the Test Product at Correct Age (18 Years or Older)

时间窗: 2 allergy seasons (up to a maximum of 2 years)

Participants who answered the question, 'What is your age?', were evaluated to provide the data for this outcome measure.

Number of Pregnant/ Breastfeeding Participants Who Consulted Physician Before Product Use

时间窗: 2 allergy seasons (up to a maximum of 2 years)

Participants who answered the question, 'Did you talk to your doctor before using Pirinase Hayfever Relief for Adults 0.05% Nasal Spray product (if consumer said yes to pregnant or breastfeeding)? ', were evaluated to provide the data for this outcome measure.

Number of Participants Who Consulted Physician if Symptoms Were Not Improved After Using Test Product for 7 Days

时间窗: 2 allergy seasons (up to a maximum of 2 years)

Participants who answered the question, 'Did you consult a doctor about your symptoms not improving after using Pirinase Hayfever Relief for Adults 0.05% Nasal Spray product for 7 days? ', were evaluated to provide the data for this outcome measure.

Number of Participants Who Did Not Exceed the Correct Frequency of Use (2 Sprays Per Nostril Per Day)

时间窗: 2 allergy seasons (up to a maximum of 2 years)

Participants who answered the question, 'When using Pirinase Hayfever Relief for Adults 0.05% Nasal Spray product, did you use more than 2 sprays in each nostril per day?,' were evaluated to provide the data for this outcome measure.

次要结局

  • Number of Participants Who Used the Test Product and Were Not Taking a Medication for Human Immunodeficiency Virus (HIV)(2 allergy seasons (up to a maximum of 2 years))
  • Number of Participants Who Consulted Physician When Test Product Was Used for 1 Month or More Continuously(2 allergy seasons (up to a maximum of 2 years))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验